Quinsam Capital Corporation is a Canadian merchant banking firm focusing on small-cap investments in sectors like technology, healthcare, and cannabis. Its financial health is strong, with a gross margin of 100% and an impressive EBITDA margin of 62.7%, indicating effective cost management. However, the low market cap of $5.09M and a share price of $0.06 suggest potential undervaluation despite high margins. Additionally, the company's return on equity and assets are relatively low at 3.6% and 3.5%, raising concerns about overall profitability and growth potential.
Loading financial metrics...
No significant red flags identified
This company appears financially healthy on available metrics
Exceptional revenue growth of 207.2% YoY demonstrates strong market demand and competitive positioning.
Debt-free balance sheet with a solid cash position, providing significant financial flexibility.
Excellent liquidity with current ratio of 5.2x ensures operational stability.
Low debt-to-revenue ratio of 0.0% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Asset Management companies of a similar size
Based on 2026-Q2 (June 30, 2026)